Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guardant Health, Inc. stock logo
GH
Guardant Health
$38.00
+2.6%
$43.39
$20.14
$52.92
$4.59B1.492.15 million shs1.37 million shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$5.49
-2.5%
$6.41
$4.64
$8.61
$2.13B1.31.58 million shs1.95 million shs
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$31.41
-1.9%
$32.99
$21.39
$35.53
$5.14B0.761.86 million shs836,498 shs
RadNet, Inc. stock logo
RDNT
RadNet
$56.61
-0.3%
$52.81
$45.00
$93.65
$4.25B1.46687,151 shs454,156 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guardant Health, Inc. stock logo
GH
Guardant Health
+2.56%-6.57%-16.90%-11.36%+68.81%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-2.49%-5.99%-13.81%-28.70%-5.51%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
-1.94%-5.48%-2.28%-1.84%+8.20%
RadNet, Inc. stock logo
RDNT
RadNet
-0.28%-7.41%+15.51%-4.81%-2.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guardant Health, Inc. stock logo
GH
Guardant Health
4.6421 of 5 stars
4.52.00.04.34.02.50.6
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.4445 of 5 stars
3.32.00.00.03.02.50.6
Option Care Health, Inc. stock logo
OPCH
Option Care Health
4.3644 of 5 stars
2.45.00.04.23.82.51.3
RadNet, Inc. stock logo
RDNT
RadNet
3.4104 of 5 stars
2.71.00.04.63.52.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guardant Health, Inc. stock logo
GH
Guardant Health
3.05
Buy$52.3237.68% Upside
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.67
Moderate Buy$8.3051.18% Upside
Option Care Health, Inc. stock logo
OPCH
Option Care Health
2.88
Moderate Buy$35.5013.02% Upside
RadNet, Inc. stock logo
RDNT
RadNet
3.40
Buy$69.7523.21% Upside

Current Analyst Ratings Breakdown

Latest LFST, OPCH, GH, and RDNT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.00
5/5/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/5/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.00
5/1/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$60.00 ➝ $65.00
5/1/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$56.00 ➝ $60.00
5/1/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.00
5/1/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$53.00 ➝ $60.00
5/1/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$65.00 ➝ $70.00
4/30/2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$38.00 ➝ $38.00
4/30/2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$38.00 ➝ $40.00
4/22/2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$36.00 ➝ $36.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guardant Health, Inc. stock logo
GH
Guardant Health
$774.00M6.08N/AN/A$1.34 per share28.36
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.28B1.66N/AN/A$3.77 per share1.46
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$5.19B0.99$1.83 per share17.19$8.03 per share3.91
RadNet, Inc. stock logo
RDNT
RadNet
$1.87B2.27$3.01 per share18.81$11.79 per share4.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guardant Health, Inc. stock logo
GH
Guardant Health
-$479.45M-$3.39N/AN/AN/A-59.05%-19,157.20%-25.96%8/6/2025 (Estimated)
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$186.26M-$0.10N/AN/AN/A-7.90%-6.66%-4.51%N/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$267.09M$1.2426.3924.932.304.37%15.30%6.57%7/30/2025 (Estimated)
RadNet, Inc. stock logo
RDNT
RadNet
$3.04M-$0.43N/A106.81N/A-0.25%4.29%1.45%8/5/2025 (Estimated)

Latest LFST, OPCH, GH, and RDNT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million
4/29/2025Q1 2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion
2/27/2025Q4 2024
RadNet, Inc. stock logo
RDNT
RadNet
$0.21$0.22+$0.01$0.07$459.42 million$477.10 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
N/AN/AN/AN/AN/A
RadNet, Inc. stock logo
RDNT
RadNet
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
6.22
5.85
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.19
1.32
1.32
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.77
1.73
1.32
RadNet, Inc. stock logo
RDNT
RadNet
0.89
2.16
2.16

Institutional Ownership

CompanyInstitutional Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
98.05%
RadNet, Inc. stock logo
RDNT
RadNet
77.90%

Insider Ownership

CompanyInsider Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
6.10%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.20%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.64%
RadNet, Inc. stock logo
RDNT
RadNet
5.12%
CompanyEmployeesShares OutstandingFree FloatOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
1,790123.89 million116.76 millionNot Optionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
6,640388.88 million357.39 millionOptionable
Option Care Health, Inc. stock logo
OPCH
Option Care Health
5,600163.75 million169.09 millionOptionable
RadNet, Inc. stock logo
RDNT
RadNet
8,97075.03 million70.24 millionOptionable

Recent News About These Companies

iCAD, Inc. Announces Merger with RadNet, Inc.
RadNet, Inc. stock logo
RadNet (NASDAQ:RDNT) Upgraded at StockNews.com
StockNews.com Upgrades RadNet (NASDAQ:RDNT) to "Sell"

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Guardant Health stock logo

Guardant Health NASDAQ:GH

$38.00 +0.95 (+2.56%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$38.40 +0.40 (+1.05%)
As of 05/23/2025 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

LifeStance Health Group stock logo

LifeStance Health Group NASDAQ:LFST

$5.49 -0.14 (-2.49%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$5.48 0.00 (-0.09%)
As of 05/23/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Option Care Health stock logo

Option Care Health NASDAQ:OPCH

$31.41 -0.62 (-1.94%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$31.00 -0.41 (-1.32%)
As of 05/23/2025 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

RadNet stock logo

RadNet NASDAQ:RDNT

$56.61 -0.16 (-0.28%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$57.78 +1.17 (+2.06%)
As of 05/23/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.